European Union Approves , Novavax Coronavirus Vaccine.<br />ABC News reports the European Union <br />has authorized the use of the <br />Novavax COVID-19 vaccine.<br />Manufactured in the United States, Novavax's two-dose vaccine will be the fifth coronavirus vaccine approved by the European Union.<br />Manufactured in the United States, Novavax's two-dose vaccine will be the fifth coronavirus vaccine approved by the European Union.<br />According to ABC News, the European Union <br />has ordered around 100 million <br />doses of the Novavax vaccine.<br />Research conducted by the <br />European Medicines Agency shows <br />"the data on the vaccine were robust and met the EU criteria for efficacy, safety, and quality.” .<br />The Novavax vaccine is protein-based, a technique long used in vaccine production. .<br />In a study of 30,000 citizens of <br />the United States and Mexico, the vaccine was <br />proven safe and 90% effective against <br />earlier variants of the coronavirus.<br />In a study of 30,000 citizens of <br />the United States and Mexico, the vaccine was <br />proven safe and 90% effective against <br />earlier variants of the coronavirus.<br />The Novavax vaccine only requires refrigeration to remain effective.<br />Experts say this trait could minimize the impact of global vaccine inequity.<br />Novavax CEO Stanley C. Erck said the decision would “deliver the vaccine to the E.U. during a critical time when we believe having choice among vaccines will lead to increased immunization.”.<br />Novavax CEO Stanley C. Erck said the decision would “deliver the vaccine to the E.U. during a critical time when we believe having choice among vaccines will lead to increased immunization.”
